This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast Support Group meeting held over Zoom. Dr. Gabriella Ilie is speaking here on Men's Mental Health and Recovery Following a Prostate Cancer Diagnosis. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast Support Group meeting held over Zoom. Dr. Scott North is the Director of Medical Oncology at the Cross Cancer Institute and a Professor in the Department of Oncology, Faculty of Medicine and Dentistry at the University of Alberta. . Dr. North is speaking here on PSMA Scans as well as the application of radioligand therapies. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's 2024 Prostate Cancer Awareness Month Active Surveillance Support Group meeting held over Zoom. Dr. Ale Berlin is a staff clinician-scientist radiation oncologist at the Princess Margaret (PM) Cancer Center. He completed his training in Chile, Israel, and Canada. His clinical practice focuses on the discovery and clinical evaluation of novel therapeutics capitalizing on genomic characterization genitourinary malignancies, and advanced molecular and MR imaging. Dr. Berlin is a PI of the NRG GU010 study investigating the use of clinicogenomic risk stratification for treatment individualization in men with localized prostate cancer. Dr. Berlin also leads a clinical initiative quantifying the human and machine performance during the clinical deployment of an in-house developed AI radiotherapy planning method for prostate cancer. Dr. Alejandro Berlin speaks here on the impact of Gleason 6 being labelled as 'cancer' on treatment decision-making. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast Support Group meeting held over Zoom. Dr. Sofie Tolmeijer and Dr. Edmond Kwan from the Vancouver Prostate Centre discuss how tumour DNA testing and germline (genes inherited from one’s parents) testing will play an increasingly important role in selecting patients for new precision therapies. --- For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's November 2023 Coast to Coast Support Group meeting held over Zoom. Dr. Shamini Selvarajah is a clinical laboratory geneticist and Assistant Professor in the Department of Laboratory Medicine & Pathobiology - Cytogenetics at the University of Toronto. She holds a PhD, FACMGG, and FCCMG. Dr. Selvarajah is speaking here on '2023 Update on Genetic Testing Recommendations for Prostate Cancer Patients.' For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's January 2024 Coast to Coast Support Group meeting held over Zoom. Dr. Leong is an Associate Professor in the Department of Medicine at McMaster University. He is the Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program. Dr. Leong completed his cardiology training, Doctor of Philosophy, Master of Public Health, and Master of Biostatistics degrees at the University of Adelaide, Australia. He completed a fellowship in cardiovascular imaging at the Leiden University Medical Centre in the Netherlands before re-locating to Canada. Dr. Leong is speaking here on Cardiovascular Health and Prostate Cancer. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's March 2024 Coast to Coast Support Group meeting held over Zoom. Dr. Jack Barkin, the founding partner and medical director of Can-Am HIFU who performed the first Canadian HIFU (High-Intensity Focused Ultrasound) treatment in 2006, is speaking to us about this 'most effective, minimally invasive' localized prostate cancer treatment. He has authored over 100 papers on different aspects of urology in medical and urologic journals, worked on over 250 clinical trials, served as a medical advisory board member for many organizations, and speaks in countries around the world. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's April 2024 Coast to Coast Support Group meeting held over Zoom. Danielle Ralic is the founder and CEO of Ancora.ai, a health tech company that connects cancer patients & their care teams to clinical trials through an AI-powered platform. She studied Finance and Information Systems with a specialty in Healthcare Information Technology at Boston College. She has over 15 years of experience implementing technology solutions in healthcare first with Deloitte in Boston working with hospitals and the public health department, and then at ZS Associates in Los Angeles and Zurich to deliver business intelligence solutions to Top10 Pharma. She is also an accomplished panelist and speaker sharing insights on advanced analytics applications in healthcare. Danielle is speaking here on Why We Should Care About Clinical Trials (And How to Stay in the Loop). For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.